Vistin Pharma ASA

OL:VISTN Norway Drug Manufacturers - Specialty & Generic
Market Cap
$85.62 Million
Nkr975.58 Million NOK
Market Cap Rank
#22239 Global
#113 in Norway
Share Price
Nkr22.00
Change (1 day)
+4.27%
52-Week Range
Nkr19.70 - Nkr26.30
All Time High
Nkr28.06
About

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

Vistin Pharma ASA - Asset Resilience Ratio

Latest as of March 2025: 3.08%

Vistin Pharma ASA (VISTN) has an Asset Resilience Ratio of 3.08% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
Nkr12.67 Million
Cash + Short-term Investments
Total Assets
Nkr411.55 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how Vistin Pharma ASA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Vistin Pharma ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Nkr12.67 Million 3.08%
Short-term Investments Nkr0.00 0%
Total Liquid Assets Nkr12.67 Million 3.08%

Asset Resilience Insights

  • Limited Liquidity: Vistin Pharma ASA maintains only 3.08% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Vistin Pharma ASA Industry Peers by Asset Resilience Ratio

Compare Vistin Pharma ASA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Vistin Pharma ASA (2016–2023)

The table below shows the annual Asset Resilience Ratio data for Vistin Pharma ASA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 6.50% Nkr26.20 Million Nkr403.40 Million +6.14pp
2022-12-31 0.35% Nkr1.44 Million Nkr407.21 Million -23.58pp
2020-12-31 23.93% Nkr77.04 Million Nkr321.92 Million -12.75pp
2019-12-31 36.68% Nkr184.91 Million Nkr504.17 Million -10.03pp
2018-12-31 46.71% Nkr233.58 Million Nkr500.06 Million +14.71pp
2016-12-31 32.00% Nkr89.44 Million Nkr279.52 Million --
pp = percentage points